Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Metabolic syndrome worsens treatment outcomes for urinary symptoms in men with enlarged prostate.

The treatment improved prostate health in mice.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Catharanthus roseus and Schwenckia americana extracts are generally safe but may cause kidney and liver tissue damage.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Finasteride safely lowers DHT levels without affecting testosterone.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride effectively blocks enzyme causing male pattern baldness.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Finasteride may cause long-lasting sexual side effects.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Long-term use of minoxidil for high blood pressure can delay kidney failure in some patients and improve kidney function in others with severe hypertension.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.